Physician profile
Stuart Donovan
NPI 1760469183
$30,563.33
in general payments reported to CMS, 2019-2025
13 companies · $653 in 2025
The $653 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $1,496 · 2021: $52.10 · 2022: $637 · 2023: $245 · 2024: $734 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $16,265.36 | 2019-2025 | Harmonic, Echelon Flex, Prolene |
| Medical Device Business Services, INC. | $11,520.00 | 2019 | |
| W. L. Gore & Associates, INC. | $884.51 | 2021-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Enform Intraperitoneal Biomaterial |
| Intuitive Surgical, INC. | $750.75 | 2019-2024 | Da Vinci Surgical System |
| Abbott Laboratories | $695.70 | 2022-2025 | Esprit, Jeti |
| Allergan, INC. | $146.14 | 2022 | |
| Covidien Lp | $107.43 | 2019 | |
| Depuy Synthes Sales INC. | $99.31 | 2025 | Surgiflo Hemostatic Matrix |
| Tela Bio, INC. | $34.02 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Vertex Pharmaceuticals Incorporated | $19.19 | 2025 | |
| Merck Sharp & Dohme LLC | $18.09 | 2025 | Bridion |
| Pacira Pharmaceuticals Incorporated | $16.64 | 2025 | Iovera, Zilretta, Exparel |
| Heron Therapeutics, INC. | $6.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Donovan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.